Organovo Holdings Stock Total Debt
| ONVO Stock | USD 1.03 0.07 6.36% |
Organovo Holdings fundamentals help investors to digest information that contributes to Organovo Holdings' financial success or failures. It also enables traders to predict the movement of Organovo Stock. The fundamental analysis module provides a way to measure Organovo Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Organovo Holdings stock.
As of the 23rd of April 2024, Total Debt To Capitalization is likely to grow to -0.0049. Organovo | Total Debt |
Organovo Holdings Company Total Debt Analysis
Organovo Holdings' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Organovo Holdings Total Debt | 1.8 M |
Most of Organovo Holdings' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organovo Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Organovo Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Organovo Holdings is extremely important. It helps to project a fair market value of Organovo Stock properly, considering its historical fundamentals such as Total Debt. Since Organovo Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Organovo Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Organovo Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
Organovo Total Debt Historical Pattern
Today, most investors in Organovo Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Organovo Holdings' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Organovo Holdings total debt as a starting point in their analysis.
Organovo Holdings Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Organovo Net Debt
Based on the latest financial disclosure, Organovo Holdings has a Total Debt of 1.8 M. This is 99.93% lower than that of the Biotechnology sector and 99.44% lower than that of the Health Care industry. The total debt for all United States stocks is 99.97% higher than that of the company.
Organovo Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Organovo Holdings' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Organovo Holdings could also be used in its relative valuation, which is a method of valuing Organovo Holdings by comparing valuation metrics of similar companies.Organovo Holdings is currently under evaluation in total debt category among related companies.
Organovo Holdings Current Valuation Drivers
We derive many important indicators used in calculating different scores of Organovo Holdings from analyzing Organovo Holdings' financial statements. These drivers represent accounts that assess Organovo Holdings' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Organovo Holdings' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 53.1M | 66.5M | 32.7M | 19.1M | 21.9M | 20.8M | |
| Enterprise Value | 25.8M | 29.2M | 6.2M | 5.6M | 6.4M | 6.1M |
Organovo Holdings Institutional Holders
Institutional Holdings refers to the ownership stake in Organovo Holdings that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Organovo Holdings' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Organovo Holdings' value.| Shares | Ubs Group Ag | 2023-12-31 | 2.6 K | Advisor Group Holdings, Inc. | 2023-12-31 | 2.1 K | Albion Financial Group (utah) | 2023-12-31 | 1.9 K | Huntington National Bank | 2023-12-31 | 750 | Wells Fargo & Co | 2023-12-31 | 410 | Bank Of America Corp | 2023-12-31 | 399 | Mcglone Suttner Wealth Management Inc | 2023-12-31 | 325 | Steward Partners Investment Advisory, Llc | 2023-12-31 | 230 | Coppell Advisory Solutions Llc | 2023-12-31 | 125 | Vanguard Group Inc | 2023-12-31 | 353.6 K | Blackrock Inc | 2023-12-31 | 147.5 K |
Organovo Fundamentals
| Return On Equity | -1.34 | ||||
| Return On Asset | -0.73 | ||||
| Operating Margin | (736.00) % | ||||
| Current Valuation | 7.25 M | ||||
| Shares Outstanding | 10.08 M | ||||
| Shares Owned By Insiders | 1.91 % | ||||
| Shares Owned By Institutions | 8.23 % | ||||
| Number Of Shares Shorted | 161.88 K | ||||
| Price To Earning | (3.67) X | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 41.91 X | ||||
| Revenue | 370 K | ||||
| Gross Profit | (8.52 M) | ||||
| EBITDA | (17.46 M) | ||||
| Net Income | (17.26 M) | ||||
| Cash And Equivalents | 26.19 M | ||||
| Cash Per Share | 3.01 X | ||||
| Total Debt | 1.8 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 20.99 X | ||||
| Book Value Per Share | 0.63 X | ||||
| Cash Flow From Operations | (12.41 M) | ||||
| Short Ratio | 1.19 X | ||||
| Earnings Per Share | (2.16) X | ||||
| Target Price | 8.55 | ||||
| Number Of Employees | 18 | ||||
| Beta | 0.9 | ||||
| Market Capitalization | 11.09 M | ||||
| Total Asset | 20.31 M | ||||
| Retained Earnings | (325 M) | ||||
| Working Capital | 13.38 M | ||||
| Current Asset | 63.65 M | ||||
| Current Liabilities | 4.49 M | ||||
| Net Asset | 20.31 M |
About Organovo Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Organovo Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organovo Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organovo Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Organovo Holdings Piotroski F Score and Organovo Holdings Altman Z Score analysis. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Organovo Stock analysis
When running Organovo Holdings' price analysis, check to measure Organovo Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organovo Holdings is operating at the current time. Most of Organovo Holdings' value examination focuses on studying past and present price action to predict the probability of Organovo Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organovo Holdings' price. Additionally, you may evaluate how the addition of Organovo Holdings to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Organovo Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 0.027 | Quarterly Revenue Growth (0.96) | Return On Assets (0.73) | Return On Equity (1.34) |
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.